|
|
|
Insider
Information: |
Gold Mitchell |
Relationship: |
Executive Chairman and... |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
457,263 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
457,263 |
|
|
Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Dendreon Corp |
DNDN |
Director |
2013-01-03 |
457,263 |
2003-09-03 |
0 |
Premium* |
|
Alpine Immune Sciences Inc |
ALPN |
Executive Chairman and... |
2024-05-20 |
0 |
2024-05-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
140 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
DNDN |
Dendreon Corp |
President & Chief Executive Of |
|
2009-10-28 |
5 |
GD |
$26.70 |
$5,020 |
D/D |
188 |
477,833 |
0 |
- |
|
DNDN |
Dendreon Corp |
President & CEO |
|
2005-06-30 |
5 |
S |
$4.45 |
$1,876 |
D/D |
(422) |
50,933 |
0 |
- |
|
DNDN |
Dendreon Corp |
President & Chief Executive Of |
|
2010-12-31 |
5 |
GD |
$37.33 |
$20,158 |
D/D |
540 |
244,895 |
0 |
- |
|
DNDN |
Dendreon Corp |
President & CEO |
|
2008-04-18 |
4 |
D |
$5.85 |
$3,621 |
D/D |
(619) |
389,071 |
0 |
- |
|
DNDN |
Dendreon Corp |
President & CEO |
|
2008-07-18 |
4 |
D |
$5.05 |
$3,126 |
D/D |
(619) |
387,523 |
0 |
- |
|
DNDN |
Dendreon Corp |
President & CEO |
|
2008-10-18 |
4 |
D |
$4.84 |
$2,996 |
D/D |
(619) |
385,975 |
0 |
- |
|
DNDN |
Dendreon Corp |
President & Chief Executive Of |
|
2010-01-18 |
4 |
D |
$29.05 |
$18,011 |
D/D |
(620) |
461,016 |
0 |
- |
|
DNDN |
Dendreon Corp |
President & CEO |
|
2009-01-18 |
4 |
D |
$4.25 |
$3,251 |
D/D |
(765) |
544,755 |
0 |
- |
|
DNDN |
Dendreon Corp |
President & CEO |
|
2009-07-18 |
4 |
D |
$22.99 |
$19,633 |
D/D |
(854) |
483,560 |
0 |
- |
|
DNDN |
Dendreon Corp |
President & CEO |
|
2009-10-18 |
4 |
D |
$29.51 |
$25,202 |
D/D |
(854) |
479,303 |
0 |
- |
|
DNDN |
Dendreon Corp |
President & CEO |
|
2010-07-18 |
4 |
D |
$31.29 |
$26,722 |
D/D |
(854) |
217,397 |
0 |
- |
|
DNDN |
Dendreon Corp |
President & CEO |
|
2010-10-18 |
4 |
D |
$37.45 |
$31,982 |
D/D |
(854) |
210,435 |
0 |
- |
|
DNDN |
Dendreon Corp |
President & CEO |
|
2010-04-18 |
4 |
D |
$38.90 |
$33,260 |
D/D |
(855) |
509,021 |
0 |
- |
|
DNDN |
Dendreon Corp |
President & Chief Executive Of |
|
2011-01-18 |
4 |
D |
$36.90 |
$31,550 |
D/D |
(855) |
238,825 |
0 |
- |
|
DNDN |
Dendreon Corp |
President & CEO |
|
2012-04-20 |
4 |
D |
$10.35 |
$9,594 |
D/D |
(927) |
630,956 |
0 |
- |
|
DNDN |
Dendreon Corp |
President & CEO |
|
2008-04-19 |
4 |
D |
$5.85 |
$5,435 |
D/D |
(929) |
388,142 |
0 |
- |
|
DNDN |
Dendreon Corp |
President & CEO |
|
2008-10-19 |
4 |
D |
$4.84 |
$4,496 |
D/D |
(929) |
385,046 |
0 |
- |
|
DNDN |
Dendreon Corp |
President & CEO |
|
2012-04-21 |
4 |
D |
$10.35 |
$9,615 |
D/D |
(929) |
630,027 |
0 |
- |
|
DNDN |
Dendreon Corp |
President & CEO |
|
2008-07-19 |
4 |
D |
$5.05 |
$4,843 |
D/D |
(959) |
386,564 |
0 |
- |
|
DNDN |
Dendreon Corp |
President & CEO |
|
2008-12-31 |
5 |
GD |
$4.58 |
$4,580 |
D/D |
1,000 |
377,546 |
0 |
- |
|
ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
|
2023-12-28 |
4 |
OE |
$0.65 |
$660 |
D/D |
1,016 |
1,016 |
0 |
- |
|
ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
|
2023-12-28 |
4 |
AS |
$20.04 |
$20,362 |
D/D |
(1,016) |
0 |
0 |
% |
|
DNDN |
Dendreon Corp |
President & CEO |
|
2008-01-19 |
4 |
D |
$6.43 |
$7,375 |
D/D |
(1,147) |
389,690 |
0 |
- |
|
DNDN |
Dendreon Corp |
President & CEO |
|
2009-01-19 |
4 |
D |
$4.25 |
$4,875 |
D/D |
(1,147) |
543,608 |
0 |
- |
|
ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
|
2021-05-20 |
4 |
AS |
$15.00 |
$18,316 |
D/D |
(1,221) |
177,853 |
0 |
% |
|
140 Records found
|
|
Page 1 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|